A randomized study of endobronchial valves for advanced emphysema.

BACKGROUND Endobronchial valves that allow air to escape from a pulmonary lobe but not enter it can induce a reduction in lobar volume that may thereby improve lung function and exercise tolerance in patients with pulmonary hyperinflation related to advanced emphysema. METHODS We compared the safety and efficacy of endobronchial-valve therapy in patients with heterogeneous emphysema versus standard medical care. Efficacy end points were percent changes in the forced expiratory volume in 1 second (FEV1) and the 6-minute walk test on intention-to-treat analysis. We assessed safety on the basis of the rate of a composite of six major complications. RESULTS Of 321 enrolled patients, 220 were randomly assigned to receive endobronchial valves (EBV group) and 101 to receive standard medical care (control group). At 6 months, there was an increase of 4.3% in the FEV1 in the EBV group (an increase of 1.0 percentage point in the percent of the predicted value), as compared with a decrease of 2.5% in the control group (a decrease of 0.9 percentage point in the percent of the predicted value). Thus, there was a mean between-group difference of 6.8% in the FEV1 (P=0.005). Roughly similar between-group differences were observed for the 6-minute walk test. At 12 months, the rate of the complications composite was 10.3% in the EBV group versus 4.6% in the control group (P=0.17). At 90 days, in the EBV group, as compared with the control group, there were increased rates of exacerbation of chronic obstructive pulmonary disease (COPD) requiring hospitalization (7.9% vs. 1.1%, P=0.03) and hemoptysis (6.1% vs. 0%, P=0.01). The rate of pneumonia in the target lobe in the EBV group was 4.2% at 12 months. Greater radiographic evidence of emphysema heterogeneity and fissure completeness was associated with an enhanced response to treatment. CONCLUSIONS Endobronchial-valve treatment for advanced heterogeneous emphysema induced modest improvements in lung function, exercise tolerance, and symptoms at the cost of more frequent exacerbations of COPD, pneumonia, and hemoptysis after implantation. (Funded by Pulmonx; ClinicalTrials.gov number, NCT00129584.)

[1]  A. H. Dinsmore,et al.  New England , 1894, Letters from America.

[2]  E. Kent,et al.  THE SURGICAL ANATOMY OF THE PULMONARY LOBES , 1942 .

[3]  J. Hogg,et al.  Elastic properties of the centrilobular emphysematous space. , 1969, The Journal of clinical investigation.

[4]  W M Thurlbeck,et al.  The resistance of collateral channels in excised human lungs. , 1969, The Journal of clinical investigation.

[5]  COLLATERAL VENTILATION IN MAN , 1978 .

[6]  N. Müller,et al.  "Density mask". An objective method to quantitate emphysema using computed tomography. , 1988, Chest.

[7]  Lloyd D. Fisher,et al.  Biostatistics: A Methodology for the Health Sciences , 1993 .

[8]  R. Rogers,et al.  Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. , 1996, The New England journal of medicine.

[9]  R. Mckenna,et al.  Should lung volume reduction for emphysema be unilateral or bilateral? , 1996, The Journal of thoracic and cardiovascular surgery.

[10]  N. Zamel,et al.  Mechanism of short-term improvement in lung function after emphysema resection. , 1996, American journal of respiratory and critical care medicine.

[11]  K. Osann,et al.  Patient selection criteria for lung volume reduction surgery. , 1997, The Journal of thoracic and cardiovascular surgery.

[12]  Michael F. McNitt-Gray,et al.  Method for segmenting chest CT image data using an anatomical model: preliminary results , 1997, IEEE Transactions on Medical Imaging.

[13]  M S Brown,et al.  Knowledge-based method for segmentation and analysis of lung boundaries in chest X-ray images. , 1998, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[14]  H. Fessler,et al.  Lung volume reduction surgery and airflow limitation. , 1998, American journal of respiratory and critical care medicine.

[15]  C. Olanow,et al.  Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. , 1999, The New England journal of medicine.

[16]  G. Criner,et al.  Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[17]  David W. Kaczka,et al.  Relation Between Preoperative Inspiratory Lung Resistance and the Outcome of Lung-Volume-Reduction Surgery for Emphysema , 1999 .

[18]  K P Whittall,et al.  Preoperative severity of emphysema predictive of improvement after lung volume reduction surgery: use of CT morphometry. , 2000, Chest.

[19]  Mitsuru Sasako,et al.  Randomised trials in surgery: problems and possible solutions , 2002, BMJ : British Medical Journal.

[20]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[21]  G. Snell,et al.  The potential for bronchoscopic lung volume reduction using bronchial prostheses: a pilot study. , 2003, Chest.

[22]  M. Polkey,et al.  Endobronchial volume reduction: a myth or a marvel? , 2004, Seminars in respiratory and critical care medicine.

[23]  D. Hansell,et al.  Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. , 2005, American journal of respiratory and critical care medicine.

[24]  G. Snell,et al.  133Xenon ventilation scintigraphy applied to bronchoscopic lung volume reduction techniques for emphysema: relevance of interlobar collaterals , 2005, Internal medicine journal.

[25]  F. Venuta,et al.  Bronchoscopic lung-volume reduction with one-way valves in patients with heterogenous emphysema. , 2005, The Annals of thoracic surgery.

[26]  H. Fessler.  Collateral ventilation, the bane of bronchoscopic volume reduction. , 2005, American journal of respiratory and critical care medicine.

[27]  F. Venuta,et al.  Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. , 2006, Chest.

[28]  D. Geddes,et al.  Collateral ventilation , 2006, Thorax.

[29]  T. Gildea,et al.  A multicenter trial of an intrabronchial valve for treatment of severe emphysema. , 2007, Journal of Thoracic and Cardiovascular Surgery.

[30]  Stephen W Lagakos,et al.  Statistics in medicine--reporting of subgroup analyses in clinical trials. , 2007, The New England journal of medicine.

[31]  Geoffrey McLennan,et al.  Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction , 2007, BMC pulmonary medicine.

[32]  G. Washko,et al.  Biological lung volume reduction: a new bronchoscopic therapy for advanced emphysema. , 2007, Chest.

[33]  K. Naunheim.  Lung-volume reduction surgery: a vanishing operation? , 2007, The Journal of thoracic and cardiovascular surgery.

[34]  D. R. Jones.  Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial , 2007 .

[35]  Sumit K. Shah,et al.  CAD in clinical trials: Current role and architectural requirements , 2007, Comput. Medical Imaging Graph..

[36]  E. Ingenito,et al.  Physiologic basis for improved pulmonary function after lung volume reduction. , 2008, Proceedings of the American Thoracic Society.

[37]  P. Macklem,et al.  Airway bypass improves the mechanical properties of explanted emphysematous lungs. , 2008, American journal of respiratory and critical care medicine.